NAUT Nautilus Biotechnology Inc: מכפיל שווי פעילות להכנסות

Nautilus Biotechnology (NAUT) is a strategic partner in proteome research aimed at accelerating drug development. The GURU.Markets terminal provides an EV/Revenue chart, where the 515595.24 metric determines this level. The business relies on the automation of single-molecule analysis to eliminate human error, establishing a unique engineering standard for high-throughput biological research.
Nautilus Bio - פילוחים אנליטיים ומדדי מפתח (NAUT)

Nautilus Biotechnology (NAUT) maintains a niche in high-precision proteomic analysis, although the monetization of pilot systems remains limited. Analyzing the EV/Revenue multiple dynamics on GURU.Markets, an investor can observe the EV-to-sales ratio, which excludes the impact of debt to identify the asset's true bottom and separate market noise from the fundamental risk of default while awaiting mass demand.